Author

Bhavani Shankara Bagepally

Scientist E, ICMR-National Institute of Epidemiology, Chennai. - Cited by 941 - Health Technology Assessment - Neuroscience - Epidemiology

Biography

Research Scientist at National Institute of Mental Health and Neurosciences, Bangalore, Karnataka, India Whichis one of the bestresearch institutes in the world he shared his research interest in the fields of Health Technology Assessment, Neuroscience, Epidemiology.
Title
Cited by
Year
The burden of neurological disorders across the states of India: the Global Burden of Disease Study 1990–2019
G Singh, M Sharma, GA Kumar, NG Rao, K Prasad, P Mathur, JD Pandian, ...The Lancet Global Health 9 (8), e1129-e1144, 2021202
35
2021
Cost-effectiveness of surgical mask, N-95 respirator, hand-hygiene and surgical mask with hand hygiene in the prevention of COVID-19: Cost effectiveness analysis from Indian …
BS Bagepally, M Haridoss, M Natarajan, K Jeyashree, M PonnaiahClinical Epidemiology and Global Health 10, 100702, 2021202
28
2021
Seroprevalence of IgG antibodies against SARS-CoV-2 in India, March 2020 to August 2021: a systematic review and meta-analysis
Seroprevalence of IgG antibodies against SARS-CoV-2 in India, March to August 21: a systematic review and meta-analysisN Jahan, A Brahma, MS Kumar, BS Bagepally, M Ponnaiah, T Bhatnagar, ...International Journal of Infectious Diseases 116, 59-67, 222
20
2022
Health‐related quality of life in rheumatoid arthritis: Systematic review and meta‐analysis of EuroQoL (EQ‐5D) utility scores from Asia
M Haridoss, BS Bagepally, M NatarajanInternational Journal of Rheumatic Diseases 24 (3), 314-326, 2021202
18
2021
Meta-analysis of economic evaluation studies: data harmonisation and methodological issues
BS Bagepally, N Chaiyakunapruk, J Attia, A ThakkinstianBMC health services research 22 (1), 1-10, 2022202
16
2022
Incremental net monetary benefit of bariatric surgery: systematic review and meta-analysis of cost-effectiveness evidences
P Noparatayaporn, M Thavorncharoensap, U Chaikledkaew, ...Obesity surgery 31 (7), 3279-3290, 2021202
15
2021
Association between aluminium exposure and cognitive functions: A systematic review and meta-analysis
BS Bagepally, R Balachandar, R Kalahasthi, R Tripathi, M HaridossChemosphere 268, 128831, 2021202
14
2021
Health-related quality of life among COVID-19 individuals: A cross-sectional study in Tamil Nadu, India
S Barani, T Bhatnagar, M Natarajan, K Gayathri, HB Sonekar, ...Clinical epidemiology and global health 13, 100943, 2022202
11
2022
10
2021
Systematic review and meta-analysis of gallstone disease treatment outcomes in early cholecystectomy versus conservative management/delayed cholecystectomy
BS Bagepally, M Haridoss, A Sasidharan, KV Jagadeesh, NK OswalBMJ Open Gastroenterology 8 (1), e000675, 2021202
9
2021
Association between lead exposure and DNA damage (genotoxicity): systematic review and meta-analysis
R Nagaraju, R Kalahasthi, R Balachandar, BS BagepallyArchives of Toxicology 96 (11), 2899-2911, 2022202
5
2022
Association between chronotype and cardio-vascular disease risk factors: A systematic review and meta-analysis
D Bhar, BS Bagepally, B RakeshClinical Epidemiology and Global Health, 101108, 2022202
5
2022
Association between blood lead levels and markers of calcium homeostasis: a systematic review and meta-analysis
K Upadhyay, A Viramgami, BS Bagepally, R BalachandarScientific Reports 12 (1), 180, 2022202
5
2022
4
2022
Association between Janus kinase inhibitors therapy and mental health outcome in rheumatoid arthritis: a systematic review and meta-analysis
GMH Shamail, M Haridoss, M Natarajan, V Joshua, BS BagepallyRheumatology and Therapy, 1-17, 2022202
4
2022
Association between occupational lead exposure and immunotoxicity markers: a systematic review and meta-analysis
R Kalahasthi, R Nagaraju, R Balachandar, BS BagepallyToxicology 65, 15307, 2022202
4
2022
Cost-effectiveness of Ezetimibe plus statin lipid-lowering therapy: A systematic review and meta-analysis of cost-utility studies
A Sasidharan, BS Bagepally, SS Kumar, KV Jagadeesh, M NatarajanPlos one 17 (6), e026456, 2022202
3
2022
Cost-effectiveness of janus kinase inhibitors for rheumatoid arthritis: a systematic review and meta-analysis of cost-utility studies
SS Kumar, M Haridoss, K Venkataraman, BS BagepallyFrontiers in Pharmacology 1, 109061, 2022202
3
2022
Efficacy and safety of baricitinib and tocilizumab in hospitalized patients with COVID-19: A comparison using systematic review and meta-analysis
JJ Cherian, M Eerike, BS Bagepally, S Das, S PandaFrontiers in pharmacology 1, 100408, 2022202
3
2022